Equities research analysts at StockNews.com initiated coverage on shares of Taro Pharmaceutical Industries (NYSE:TARO – Get Free Report) in a note issued to investors on Thursday. The brokerage set a “strong-buy” rating on the stock. Separately, HC Wainwright lowered shares of Taro Pharmaceutical Industries from a “buy” rating to a “neutral” rating and set a […]